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Influenza epidemics and pandemics have significant impacts on economies, morbidity
and mortality worldwide. The ability to rapidly and accurately sequence influenza viruses
is instrumental in the prevention and mitigation of influenza. All eight influenza genes
from an influenza A virus were amplified by PCR simultaneously and then subjected to
sequencing on a MinION nanopore sequencer. A complete influenza virus genome was
obtained that shared greater than 99% identity with sequence data obtained from Illumina
MiSeq and traditional Sanger-sequencing. The laboratory infrastructure and computing
resources used to perform this experiment on the MinION nanopore sequencer would be
available in most molecular laboratories around the world. Using this system, the concept
of portability, and thus sequencing influenza viruses in the clinic or field is now tenable.
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Introduction
Next-generation sequencing technologies (NGS) are now capable of providing a whole genome
sequence formost organisms (Vernikos et al., 2015). As such technologies have becomemore trusted,
they are being applied with increasing frequency in clinical microbiology laboratories to detect and
characterize pathogens; replacing the incumbent Sanger-sequencing methods (Bertelli and Greub,
2013; Quinones-Mateu et al., 2014). Sanger-sequencing has certainly been a reliable and robust
method which has served molecular biology well for over three decades (McGinn and Gut, 2013).
However, it is labor-intensive, slow, and not easily adapted for processing large genomes or large
numbers of samples.
The characterisation of influenza viruses has certainly benefitted from whole genome sequencing
(WGS) using Sanger-sequencing, providing a tool for surveillance of the highly dynamic genomes
of influenza viruses (Ghedin et al., 2005). Such data can assist in vaccine development, detection of
anti-viral drug resistance, or the identification of new reassortant influenza viruses. These advances
may help to mitigate the morbidity and mortality of influenza pandemics or seasonal epidemics.
Latterly, NGS platforms such as the IlluminaMiSeq and Life Technologies Ion Torrent have received
much acclaim about their ability to provide WGS data for influenza, potentially within 2–3 days of
the receipt of a sample (Van den Hoecke et al., 2015). Such methods often use amplicon sequencing,
where each of the eight gene segments are amplified individually or using generic primers (Van den
Hoecke et al., 2015). Primers targeting the highly conserved 50 and 30 termini of each gene segment
allow for simultaneous amplification of all segments within a single PCR reaction (Zhou et al., 2009).
The use of a specific PCR avoids the issue of concomitant sequencing of host RNA (or DNA) that
can occur in a metagenomic approach (Nakamura et al., 2009; Hall et al., 2014; Li et al., 2015). It
then becomes possible to obtain WGS for influenza viruses that are present at low concentrations in
a sample, as is commonly observed for clinical material.
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However, there are also difficulties that attend the use of NGS
for sequencing influenza. Such technologies require specialized
instrumentation and reagents that are likely to be beyond the remit
of diagnostic or regional reference laboratories. Furthermore,
although the cost of NGS is decreasing, it is still prohibitive unless
large numbers of samples are to be processed. There is clearly a
place for a low-cost and portable NGS instrument that can be
deployed more widely.
The MinION nanopore sequencing device has the potential
to be the world’s first mobile sequencer (Quick et al., 2014).
It is a small device (10 cm  2 cm  3.3 cm; approximately
90 g) and is powered by a computer USB port. Analysis of
sequencing data is done in real time by an internet-connected
laptop. Another unique feature of the device is the ability to
generate very long reads of up to 60 kilobases (Madoui et al., 2015).
It has been successfully applied for sequencing whole genomes of
E. coli, poxviruses and lambda bacteriophage (Quick et al., 2014;
Kilianski et al., 2015). It has also been applied to identify antibiotic
resistance genes in repetitive regions of the genome of Salmonella
typhi (Ashton et al., 2015). The MinION may therefore provide
new opportunities in infectious disease diagnostics, for example,
in the rapid sequencing of viral genomes in the clinic in response
to the early phase of an influenza pandemic; or determination of
ebola virus genotypes during an outbreak in a remote location.We
show that whole genome sequence of a human (and animal) viral
pathogen, the influenza virus, can be readily obtained using the
MinION nanopore sequencer. These data are compared with an
established Sanger-sequencing method and another NGS device,
the Illumina MiSeq.
Materials and Methods
Nucleic Acid Extraction
The influenza A/New Zealand/316/2014 (H3N2) isolate was
obtained from the culture collection at New Zealand’s World
Health Organization National Influenza Centre, based at the
Institute of Environmental Science and Research (ESR). RNA was
extracted from 200 mL of MDCK-SIAT viral culture supernatant
using the iPrep Purelink Virus kit (Life Technologies, Carlsbad,
CA, USA), with elution into 50 mL of RT-PCR molecular grade
water (Ambion, Austin, TX, USA).
Sanger-sequencing
The eight influenza gene segments were first amplified using the
RT-PCR protocol published by Deng et al. (2015). Briefly, cDNA
was made using uni-12 primer [50-AGCAAAAGCAGG] with
ThermoScript RT-PCR system for first-strand cDNA synthesis kit
(Invitrogen) as per the manufacturer’s instructions. Then 2 ml
cDNA was added in 17 separate PCR reactions with Platinum
Taq DNA polymerase high fidelity kit (Invitrogen) using gene
specific primers that tagged with M13 universal sequences to
the 50 end. The PCR program used were as follows: 2 min at
94°C, then 35 cycles of 30 s at 94°C, 30 s at 55°C, and 1 min at
68°C, with a final extension at 68°C for 2 min. PCR amplicons
were visualized by E-gel (Invitrogen), followed by ExoSAP IT (GE
Healthcare) purification and used for sequencingwith the forward
and reverse M13 primers with Big Dye Terminator Reaction Mix
(Applied Biosystems). The products were purified by Big Dye
XTerminator Purification Kit (Applied Biosystems) and run on
ABI 3500 XL Genetic Analyzer (Applied Biosystems). Sequencing
results were analyzed using the DNASTAR Lasergene 9 package.
The A/New Zealand/316/2014 full genome sequence is publically
available from the GISAID EpiFlu database1 (accession numbers
EPI587441-EPI587448).
Illumina MiSeq High-throughput Sequencing
The eight influenza gene segments were amplified simultaneously
in a single reaction using an RT-PCR with a single set of primers
(MBTuni-12 [50-ACGCGTGATCAGCAAAAGCAGG] and
MBTuni-13 [50-ACGCGTGATCAGTAGAAACAAGG]) (Zhou
et al., 2009), including some modifications. Briefly, a 25 mL
reaction was used for the Invitrogen Superscript III One-Step
RT-PCR system with Platinum Taq DNA polymerase (Life
Technologies) as per the manufacturer’s instructions, including
5 mL of template RNA. The thermocycling parameters were as
follows: 60 min at 42°C, 2 min at 94°C, and then 5 cycles of 30 s
at 94°C, 30 s at 45°C and 3 min at 68°C, followed by 35 cycles
of 30 s at 94°C, 30 s at 57°C and 3 min at 68°C, with a final
extension at 68°C for 2 min. PCR amplicons were visualized by
agarose gel electrophoresis, followed by purification using the
QIAquick PCR purification kit (Qiagen, Valencia, CA, USA)
and DNA quantitation using the Qubit dsDNA BR assay (Life
Technologies).
A sequencing library was then prepared using the Illumina
TruSeq DNA Nano Library preparation kit (Illumina, San Diego,
CA, USA), followed by sequencing of 250-bp paired-end reads on
an Illumina MiSeq instrument (New Zealand Genomics Limited,
Massey Genome Service, Palmerston North, New Zealand).
FastQC2 was used to check sequence data quality. Paired-
end reads were then mapped in Bowtie2 (version 2.2.4)
(Langmead and Salzberg, 2012) to a reference genome Influenza
A/Christchurch/503/102 (H3N2), which was accessed from
the Global Initiative on Sharing Avian Influenza Data EpiFlu™
Database1. Consensus sequence calling used SAMTools (Li et al.,
2009). Data visualization was executed using Tablet (Milne et al.,
2010) and Geneious R8 (Biomatters, New Zealand).
MinION Library Preparation and Sequencing
This work was completed as part of the Oxford Nanopore
Technologies (ONT) MinION early-access program. The Oxford
Nanopore MinION Genomic DNA Sequencing kit (version 4)
was used to prepare purified PCR amplicons (as for the Illumina
MiSeq; see above) for sequencing according to the manufacturer’s
instructions. Briefly, library preparation was as follows: 1 mg
of purified PCR amplicon was diluted to 80 mL using RT-PCR
molecular grade water (Ambion). The end repair process required
the addition of 5 mL of Oxford Nanopore DNA CS and then
use of the NEBNext End Repair module (New England Biolabs,
Ipswich, MA, USA) by adding 10 mL of reaction buffer and 5 mL
of enzyme, followed by a 30 min incubation at 25°C. The end
repairedDNAwas then purified using 100mLAgencourt AMPure
1http://www.gisaid.org/
2http://www.bioinformatics.babraham.ac.uk/projects/fastqc/
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FIGURE 1 | Comparative analysis of influenza genome
coverage, comparing the Illumina MiSeq, and the MinION
nanopore sequencer. Sequence coverage profiles for each
influenza gene segment are plotted. The left-hand y-axis shows x-fold
coverage for the Illumina MiSeq. The right-hand y-axis shows x-fold
coverage for the MinION. The x-axis shows the position in the gene.
XP beads (Beckman Coulter Inc., Pasadena, CA, USA), as per
the manufacturer’s instructions with elution into 25 mL of RT-
PCR molecular grade water (Ambion). The NEBNext dA-tailing
module (New England Biolabs) then required the addition of 3mL
of 10X reaction buffer and 2 mL of Klenow Fragment, followed by
incubation of 30 min at 37°C.
8 mL nuclease-free water was added to 30 mL of the dA-tailed
DNA, and then 10 mL adapter mix, 2 mL HP adapter and 50 mL
Blunt/TA DNA ligase mastermix (New England Biolabs) were
added in this order, and then incubated at 25°C for 10 min.
The ligated DNA was purified using His-tag Dynabeads. Beads
were first prepared by washing in 200 mL of 1X ONT wash buffer
twice, and then resuspended in 100 mL of 2X ONT wash buffer.
The ligated DNA was mixed directly with the prepared beads and
incubated at 25°C for 5 min. The beads were then washed twice
again with 1X ONT wash buffer. 25 mL of ONT elution buffer
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was added to the beads with a 10 min incubation at 25°C. After
removal of the beads, 6mL of the eluatewas combinedwith 141mL
EP buffer and 3 mL fuel mix, to provide the final sequencing
library.
Before loading the library, the MinION device was connected
to a computer and a flow cell (R7.3) inserted. A flow cell quality
control check was run using the MinKNOW control software to
assess pore activity. This was followed by equilibration of the flow
cell with two aliquots of 150 mL priming mix (containing fuel
mix and EP buffer), and observing a 10 min incubation between
loading each aliquot.
The sequencing library was loaded into the flow cell. A 48-h
sequencing protocol was selected on theMinION control software
(version 0.46.1.9). The sequencing protocol was run for a total of
4 h.
MinION Data Analysis
Raw sequence data was uploaded in real-time for base calling
analysis using the cloud-basedMetrichor workflow rx2.22-44717-
dg-1.6.1-ch-1.6.3 rev 1.9 with the quality filter on. Reads in fastq
format were then extracted from downloaded HDF5 format files
(fast5) using poretools (Loman andQuinlan, 2014).Mapping used
the same influenza reference genome as for the Illumina MiSeq
data, but was performed using LASTAL (Frith et al., 2010) with
the command line: lastal –s 2 –T 0 –Q 0 –a 1. SAMTools (0.1.19-
44428cd) was used to convert the data into bam format. Tablet
(1.14.04.10) and Geneious R8 (Biomatters, New Zealand) were
used for visualization.
MinION sequence data has been deposited in the European
Nucleotide Archive under project accession number PRJEB9812,
available at www.ebi.ac.uk/ena.
Results
430 nanopores were available on the flowcell based on
the Platform QC report generated by the control software
(MinKNOW) prior to sequencing run commencement. In total,
118,052 sequence reads were produced in 4 h of run time (mean
length 915 bp), with 17,108 reads categorized as high quality two-
direction (2D) reads (mean length 955 bp). Sequence alignment to
a prototypic reference genome was undertaken using the software
package LASTAL, and full coverage of all influenza genes
was achieved (Figure 1). Influenza sequence accounted for over
86.46% (14,793 reads) of the available 2D sequence data (Table 1).
For comparison, single-tube PCR amplicons from the same
influenza A (H3N2) influenza isolate were run on an Illumina
MiSeq, producing 2,999,678 sequence reads of 250 bp in length.
Bowtie2 was used to map sequence data to the same prototypic
reference genome, resulting in 100% coverage, just as observed for
theMinION nanopore sequencer (Figure 1). The coverage for the
MiSeq was higher than for theMinION, due to the higher number
of reads generated in the IlluminaMiSeq run. The coverage for the
MinION appears to be more even across the entire gene segment
for HA, NA, NP, MP, and NS, as compared to coverage observed
for the MiSeq.
The Illumina MiSeq dataset showed 100% identity with
the Sanger-sequence genome of the influenza (H3N2) virus
(Figure 2). The MinION nanopore sequencer also showed high
concordance with the Sanger-sequence data, having greater than
99% pairwise identity across the genome (Figure 2).
Discussion
A whole genome sequence of an influenza virus was produced
on the MinION nanopore sequencer using amplicon sequencing.
All eight influenza gene segments from an influenza A (H3N2)
virus were amplified simultaneously in a single PCR tube. This
PCRmethod has previously been published, where primers target
the conserved 12/13 base-pair viral RNA termini common to each
influenza gene, and are conserved across all influenza A subtypes
(Zhou et al., 2009). Amplicons were placed through the standard
genomic DNA MinION workflow. The eight gene segments
range in size from 0.89 to 2.3 kilobases, and amplification
bias was apparent as reflected in the differing coverage for
each gene segment (Figure 1) — an effect that has previously
been documented (Van den Hoecke et al., 2015). Refined
methods have now become available to limit this bias, which
include adjustments of PCR primer concentrations, annealing
temperature and elongation time (Van den Hoecke et al., 2015).
The nucleotide discrepancies observed between the genome
generated by the MinION as compared to the other methods are
minimal but will still need to be resolved before the technique
can be applied more widely. These discrepancies were distributed
randomly throughout the genome and are most likely the result of
sequencing error, as has been documented by others (Mikheyev
and Tin, 2014; Quick et al., 2014; Kilianski et al., 2015). The per
base accuracy of the MinION has been reported at between 65
and 80% (Kilianski et al., 2015). Therefore, discrepant nucleotides
in the MinION-generated genome are not likely to represent
genuine mutations that were missed by either Sanger-sequencing
or the Illumina MiSeq. Point mutations can have significant
phenotypic effects on influenza viruses, for example, in the
neuraminidase gene they may confer resistance to antiviral drugs
such as oseltamivir (Yen et al., 2006). It is therefore important
that 100% identity with conventional sequencing approaches is
attained before deployment in the clinic or field.
It is also unclear why the a proportion of the sequence
reads generated in the MinION dataset are longer than the
gene segment length, i.e. gene segment 4 (haemagglutinin) is
1,733 bp in length but records a maximum sequence read of
2,766 bp in the alignment (Table 1). This could be accounted
for by the generation of chimeric amplicons during the PCR,
where incomplete extension during the elongation phase of PCR
provides heterologous templates for primers to bind to (Smyth
et al., 2010). We could not provide direct evidence for this
occurring but such an effect would not be able to be detected
by a short-read NGS technology, even in the event where a
chimeric junction is sequenced, as constraints of the mapping
process would exclude such short reads from the final assembly.
Similarly, Sanger-sequencing would be unlikely to reveal such
chimera if they were rare enough (for example < 5%). However,
an alternative explanation must be considered that an artifact
of analysis or detection in the MinION instrument accounts for
the apparent longer read lengths. Mapping of the MinION data
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TABLE 1 | Sequence read lengths and the proportions of reads assigned to the influenza genome.
Gene segment (Gene name) 1 (PB2) 2 (PB1) 3 (PA) 4 (HA) 5 (NP) 6 (NA) 7 (M) 8 (NS) Total
Gene length (bp) 2,341 2,341 2,233 1,733 1,537 1,448 1,027 890 13,550
No of 2D reads assigned 59 702 1,931 395 216 1,755 4,191 5,544 14,793
Percentage of total 2D reads 0.34% 4.10% 11.29% 2.31% 1.26% 10.26% 24.49% 32.41% 86.46%
Mean read length (bp) 1,243 245 490 1,498 1,259 1,418 1,045 913 –
Median read length (bp) 1,961 448 465 1,765 1,519 1,472 1,078 927 –
5th percentile (bp) 452 376 394 563 464 776 676 711 –
95th percentile (bp) 2,406 1,088 898 1,878 1,655 1,559 1,134 984 –
Minimum read length (bp) 313 206 211 369 343 223 171 283 –
Maximum read length (bp) 2,473 2,351 2,347 2,766 2,045 2,366 2,045 2,766 –
FIGURE 2 | Pairwise nucleotide sequence identity between influenza gene segments sequenced by Sanger-sequencing, Illumina MiSeq, and the
MinION nanopore sequencer. Gene names are also shown.
using BWA (Li, 2013) was found to provide very similar results
to LAST (data not shown), indicating that the mapping software
is probably not the cause of such artifacts. In silico generation
of chimeric sequence could occur if strand displacement at the
nanopore is not recognized by the instrument during a run. This
is speculation and further work will be required to resolve the
reason for the increased apparent read lengths relative to the size
of the original gene segments (data available from the European
Nucleotide Archive; accession number PRJEB9812). It must be
noted that themajority ofMinION reads are of comparable length
to their respective gene segments, i.e. 95% of reads mapping to
HA are less than 1,878 bp, compared to the HA gene length of
1,733 bp (Table 1). The median read length for HA, NA, M, and
NS is slightly longer than the gene segment length (Table 1),
which could be due to sequencing of adaptors or insertions caused
by sequencing error. Blast search of the unmapped portion of
sequences failed to show any similarity with known sequences in
genbank (data not shown).
The PA and PB1 genes appear to have higher coverage at the
50 and 30 termini, but lower coverage in the middle of the gene
(Figure 1). This effect is observed in both MiSeq and MinION
data. It is apparent to a lesser extent in the PB2 gene (probably
masked by the low coverage in this gene). This is likely to have
been caused by the presence of defective interfering viral particles,
and very similar coverage profiles for NGS data have been noted
before for PB2, PB1, and PA genes (Saira et al., 2013). Defective
interfering virus particles of influenza have incomplete genomes,
especially having truncated copies of PB2, PB1 and PA genes
(Saira et al., 2013). This has resulted in an apparent lower median
(and mean) read length for these genes in the MinION data
(Table 1), which is an artifact of the short amplicons generated by
the defective particles, rather than from the sequencing process
itself.
The base-calling analysis for the MinION nanopore sequencer
is an area of active development, as is the development of flowcells
and associated enzymatic chemistries. The best quality sequence
data are termed 2D reads. These are the consensus reads produced
by comparing both the template and complementary strand
sequences that are obtained when the double-helix is unwound
and passed through the nanopore as a single-strand (Quick et al.,
2014). Currently there are two technical aspects which affect the
ability to produce 2D reads, those being the accuracy ofmeasuring
the electropotential across the nanopore, and the efficiency of the
motor protein and hairpin adaptor binding. In the present study,
2D data account for 14.49% of the total reads. This figure is lower
than previously published work by Quick et al (Quick et al., 2014)
who report 22.6% 2D data when using the R7.3 flowcell. Although
the accuracy of MinION sequence data is an area of active
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development and increases in data quality are anticipated (Bayley,
2015), this study shows the platform is already suitable for rapid
influenza virus detection and provision of a draft genome. A 4 h
run time for the MinION provides enough data to generate a
reliable genome. But in order to attain 100% identity with other
methods it will be necessary to increase sequence depth, most
likely by an increase in run time.
Other single molecule sequencers, i.e., Helicos (Thompson and
Steinmann, 2010) and Pacific Biosciences (Flusberg et al., 2010;
McCarthy, 2010), require significant amounts of laboratory space,
specialized equipment and large-scale computing resources. The
MinION sequencer is small and portable. Run control and data
analysis in this study were done in real-time using a moderate
specification laptop (minimum hardware requirements: i7 CPU,
8 Gb RAM, and 128 GB solid state hard disk). This is in direct
contrast to the high-end computing resources and expertise
required to process short-read high throughput sequencing data
for other platforms. The small footprint, potential for portability,
and the use of common molecular biology equipment and
reagents are attractive factors which show the MinION nanopore
sequencer has potential in diagnostic applications. Furthermore,
the short-run time of 4 h utilized in this study is a realistic
timeframe for the production of clinically useful information. This
study shows it is conceivable that investigators working in the
field, for example, during an influenza pandemic or outbreak,
could analyze samples on-site and draw initial conclusions on
subtype, reassortants, pathogenicity and antiviral drug sensitivity
(Barzon et al., 2013; Jones, 2015). The MinION nanopore
sequencer can provide a useful method for diagnostic, research
and reference laboratories to readily obtain full length influenza
virus genomes.
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